首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Limb occlusion after endovascular repair of abdominal aortic aneurysms with supported endografts.
【24h】

Limb occlusion after endovascular repair of abdominal aortic aneurysms with supported endografts.

机译:血管内修复腹主动脉瘤并支持内移植后的四肢阻塞。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To assess the time period of onset, etiology, and outcomes of limb occlusion after endovascular repair of abdominal aortic aneurysms with supported endografts. MATERIALS AND METHODS: From 1998 to 2007, 288 patients underwent endovascular aneurysm repair (EVAR) to exclude an infrarenal aortic aneurysm. In the majority of patients, a Zenith stent-graft (n = 187) or Excluder stent-graft (n = 71) was implanted. Nine patients presented with limb occlusion during follow-up. All occluded stent-grafts were modular (n = 8) or aortomonoiliac (n = 1) Zenith endoprostheses. One additional patient who was previously treated with a Zenith aortomonoiliac stent-graft was referred to our institution for further treatment of stent-graft thrombosis. RESULTS: The initial clinical presentations were acute ischemia (n = 5), buttock claudication (n = 3), and incidental findings on follow-up imaging (n = 2). Occlusion occurred within the first month after EVAR (n = 5), between the first and second month after EVAR (n = 2), 10 months after EVAR (n = 1), and 4-5 years after EVAR (n = 2). Underlying causes of occlusion were kinking of the stent-graft (n = 5), small-diameter endograft limb with extension to the external iliac artery (n = 3), and migration and dislocation of an endograft limb (n = 2). Treatment consisted of catheter-directed thrombolysis and stent placement (n = 3), surgical thrombectomy or bypass operation (n = 5), and expectant management (n = 2). Outcome of all revascularization procedures showed immediate clinical success in all patients and no late recurrent limb ischemia at a mean follow-up of 38.9 months. CONCLUSIONS: Limb occlusion of aortic stent-grafts mostly occurs shortly after EVAR and can be related to underlying kinking of the metallic skeleton, extension of the stent-graft into the external iliac artery, or migration and dislocation of an endograft limb. Satisfactory and durable clinical outcomes can be obtained after appropriate revascularization.
机译:目的:评估腹主动脉瘤支持内移植后腔内修复后的发病时间,病因和肢体闭塞的结果。材料与方法:从1998年至2007年,共有288例患者接受了血管内动脉瘤修复(EVAR),以排除肾下主动脉瘤。在大多数患者中,植入了Zenith支架移植物(n = 187)或Excluder支架移植物(n = 71)。 9例患者在随访期间出现肢体阻塞。所有闭塞的支架移植物均为模块化(n = 8)或主动脉mono(n = 1)Zenith假体。另一名先前曾用Zenith主动脉单支支架植入物治疗的患者被转诊到我们机构,以进一步治疗支架植入物血栓形成。结果:最初的临床表现为急性缺血(n = 5),臀部c行(n = 3)和随诊影像学的偶然发现(n = 2)。闭塞发生在EVAR之后的第一个月内(n = 5),在EVAR之后的第一个月和第二个月之间(n = 2),在EVAR之后的10个月内(n = 1)和在EVAR之后的4-5年内(n = 2) 。闭塞的根本原因是支架移植物的扭结(n = 5),小直径的移植物内肢延伸至外动脉(n = 3)以及移植物内肢的迁移和脱位(n = 2)。治疗包括导管定向溶栓和支架置入(n = 3),外科血栓切除术或搭桥术(n = 5)以及预期治疗(n = 2)。所有血运重建程序的结果均显示,所有患者均可立即获得临床成功,平均随访38.9个月,无晚期肢体缺血再发。结论:主动脉支架移植物的肢体闭塞多发生在EVAR后不久,并且可能与金属骨架的潜在扭结,支架移植物伸入外动脉或移植物内肢的移位和脱位有关。适当的血运重建后可获得令人满意和持久的临床结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号